Key facts
- Notable investors include Enterprise Ireland.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Magnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Magnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Magnostics
Producer of magnetic nanoparticles intended to enable rapid and efficient separation of proteins, nucleic acids, and cells. The company offers Aurosphere superparamagnetic beads with high magnetization and surface chemistries, including carboxylic acid, streptavidin, and silica, enabling biotechnology and MedTech companies to perform in vitro diagnostics, bioseparations, and high-throughput screening with improved speed, recovery, and reproducibility.
- Sector
- Healthcare
- HQ
- Dublin, Ireland
- Founded
- 2017
- Employees
- 10
- Website
- magnostics.com/
- Ownership
- Privately Held (backing)
Magnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Magnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Magnostics in its N-PORT filings yet. We sweep new filings monthly.